Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,753 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06020885 | Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study. | active not recruiting | Phase 1 | 18 | Sun Yat-sen UniversityOTHER | 1 | Jul 21, 2025 | clinicaltrials |
| NCT03984357 | Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma(PLATINUM) | completed | Phase 2 | 152 | Sun Yat-sen UniversityOTHER |
| 1 |
| Jul 17, 2025 |
| clinicaltrials |
| NCT04907370 | PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma(DIAMOND) | active not recruiting | Phase 3 | 532 | Sun Yat-sen UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT05173246 | JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma | recruiting | Phase 2 | 43 | Sun Yat-sen UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06326437 | Dyadic Intervention for Psychological Distress of Patients With Colorectal Cancer and Their Spouses | completed | N/A | 90 | Sun Yat-sen UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06710860 | ScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study Protocol | not yet recruiting | N/A | 314 | Sun Yat-sen UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07064681 | The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)(MORNING-RWS) | recruiting | — | 100 | Sun Yat-sen UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07066280 | Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer | recruiting | Phase 3 | 326 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07062328 | A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC(HP-BTC-002) | not yet recruiting | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 0 | Jul 14, 2025 | clinicaltrials |
| NCT07060599 | Human-AI Collaborative INSIGHT Diagnostic Workflow for in Breast Cancer With Extensive Intraductal Component(INSIGHT-EIC) | not yet recruiting | N/A | 480 | Sun Yat-sen UniversityOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07061717 | Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer | not yet recruiting | Phase 3 | 474 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT07059338 | Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer(HERBIC) | not yet recruiting | Phase 2 | 34 | Sun Yat-sen UniversityOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT04833257 | Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC | completed | Phase 2 | 63 | Sun Yat-sen UniversityOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT07052734 | Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients(BC-MRS-01) | completed | — | 2,843 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2025 | clinicaltrials |
| NCT01815853 | Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer(Neo-CRAG) | completed | Phase 3 | 620 | Sun Yat-sen UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT07051083 | Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale(MICS-BC) | recruiting | — | 480 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06686459 | A Phase II Clinical Trial of Artificial Intelligence-assisted One-stop Radiotherapy for Breast Cancer After Breast-conserving Surgery(BC-AIO) | recruiting | N/A | 860 | Sun Yat-sen UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07046195 | Optimal Combination of Adjuvant Radiotherapy and Immunotherapy for Breast Cancer | active not recruiting | — | 250 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT07043491 | Comparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy | recruiting | — | 2 | Sun Yat-sen UniversityOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT07032532 | Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23) | not yet recruiting | Phase 2 | 35 | Sun Yat-sen UniversityOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07012954 | ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC | recruiting | Phase 1 / Phase 2 | 64 | Sun Yat-sen UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT07028047 | Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study | not yet recruiting | Phase 1 | 64 | Sun Yat-sen UniversityOTHER | 0 | Jun 19, 2025 | clinicaltrials |
| NCT07028437 | The Effect of Endoscopy-assisted Transoral Parotid Gland Tumor Excision Compared With Traditional Operation | completed | N/A | 30 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 19, 2025 | clinicaltrials |
| NCT06013618 | Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma | recruiting | Phase 2 | 120 | Sun Yat-Sen University Cancer CenterOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07003620 | Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial | recruiting | Phase 2 | 34 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jun 17, 2025 | clinicaltrials |
| NCT07021950 | AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal Cancer | not yet recruiting | Phase 2 | 130 | Sun Yat-sen UniversityOTHER | 0 | Jun 15, 2025 | clinicaltrials |
| NCT03847857 | Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030) | active not recruiting | Phase 3 | 360 | Sun Yat-sen UniversityOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT04548440 | Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients | completed | Phase 2 | 50 | Sun Yat-Sen University Cancer CenterOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT05319574 | SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer(SACTION01) | active not recruiting | Phase 2 | 46 | Sun Yat-sen UniversityOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT04957901 | The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study | recruiting | — | 60 | Sun Yat-sen UniversityOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT06533722 | Adaptive Therapy for Post-Second-Line Advanced Breast Cancer | completed | Phase 2 | 10 | Sun Yat-sen UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT06924398 | Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC(ARMOR2501)(ARMOR2501) | recruiting | Phase 2 | 32 | Sun Yat-sen UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT07012174 | Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer | completed | — | 142 | Sun Yat-sen UniversityOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT06678048 | Arsenous Acid for Refractory Triple-Negative Breast Cancer | recruiting | Phase 2 | 12 | Sun Yat-sen UniversityOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT07007689 | A Multi-omics Study of BRAF V600E Mutant Colorectal Cancer | not yet recruiting | — | 200 | Sun Yat-sen UniversityOTHER | 0 | Jun 6, 2025 | clinicaltrials |
| NCT07008716 | Omitting CTV for Primary Tumor in LS-SCLC | recruiting | Phase 3 | 852 | Sun Yat-sen UniversityOTHER | 1 | Jun 6, 2025 | clinicaltrials |
| NCT06742502 | Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL(Si-Ri) | recruiting | Phase 2 | 30 | Sun Yat-sen UniversityOTHER | 1 | Jun 5, 2025 | clinicaltrials |
| NCT06904300 | Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer | not yet recruiting | Phase 2 | 110 | Sun Yat-sen UniversityOTHER | 0 | Jun 5, 2025 | clinicaltrials |
| NCT06947811 | A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations(APEAK) | recruiting | Phase 1 / Phase 2 | 71 | Sun Yat-sen UniversityOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT06846489 | Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma | recruiting | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Jun 3, 2025 | clinicaltrials |
| NCT06827717 | Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma | recruiting | Phase 2 | 29 | Sun Yat-sen UniversityOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT06998745 | The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients | recruiting | N/A | 327 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | May 31, 2025 | clinicaltrials |
| NCT04084496 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | recruiting | Phase 2 | 80 | Sun Yat-sen UniversityOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT05727163 | FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients | recruiting | Phase 2 | 194 | Sun Yat-sen UniversityOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT06208371 | Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM | recruiting | Phase 3 | 117 | Sun Yat-sen UniversityOTHER | 1 | May 30, 2025 | clinicaltrials |
| NCT05481463 | Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 22 | Sun Yat-sen UniversityOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT06992336 | Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy | recruiting | Phase 2 | 411 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT05892289 | Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer | recruiting | N/A | 42 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT06977074 | PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC(PROPHET) | recruiting | Phase 2 | 83 | Sun Yat-sen UniversityOTHER | 1 | May 23, 2025 | clinicaltrials |
| NCT06986538 | Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance(MARCH) | not yet recruiting | N/A | 1,064 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | May 23, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials